Tag: Europe
-
Novartis Gains Synthetic Protein Therapies for Covid-19
Global drug maker Novartis is gaining access to two Covid-19 therapy candidates made from a library of synthetic protein components.
-
Bayer Gains Gene Therapy Biotech in $4B Deal
Global drug maker Bayer AG is acquiring the company Asklepios BioPharmaceutical, developer of gene therapies to treat inherited disorders.
-
Myeloma Drug Shown to Treat Covid-19 Patients
Results from an early clinical trial show a drug designed to treat multiple myeloma also reduces viral loads and hospital stays of patients with Covid-19 infections.
-
Blood Test Shown to Predict Covid-19 Symptom Severity
A blood test that measures the ratio of two key immune system proteins is shown in tests with patients to predict the severity of Covid-19 symptoms.
-
Stimulation Device Shown to Reduce Tinnitus Symptoms
Results from a clinical trial show a device that sends audio and electrical signals to the ears and tongue reduces tinnitus symptoms for as long as one year.
-
Int’l Lab Network to Assess Covid-19 Vaccines
Six clinical testing laboratories worldwide plan to evaluate vaccines for protecting against Covid-19 infections with a common set of test protocols.
-
Digital Sedation Company Raises $11.8M in Early Funds
A Belgian company creating virtual reality systems for sedation in surgery and invasive procedures is raising €10 million in its first venture funding round.
-
Biotechs, Pharmas Vow Not to Rush Covid-19 Vaccines
In a joint statement today, CEOs of nine companies promised to follow the highest ethical and scientific standards in development and testing of their Covid-19 vaccines.
-
Small Antibody Shown to Block Covid-19 Infection
Researchers in Sweden found a small-scale antibody grown in an alpaca that in lab tests blocks the SARS-CoV-2 infection mechanism.
-
Brain Signal Synchronization Device in Development
An implantable mental health therapy system is being designed to synchronize signaling rhythms from various regions of the brain.